Join to access to all OVN content. Join for Free

Results for 'ICI'

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
OVN Avatar Forbes Books Press Release Official
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Voices of Oncology, Cancer cures, Oncology Voice Network, Kirk V. Shepard, Ramin Farhood, Forbes Books, Cancer treatment innovation, Oncology collaboration, Patient engagement in oncology, Precision medicine cancer

Voices of Oncology: Fostering a Collaborative Community of Experts to Accelerate Cancer Cures is a book by Kirk V. Shepard, M.D., and Ramin Farhood, PharmD, M.B.A., featuring insights from 33 contributors in the oncology field. It is available on platforms like Amazon and Barne…

Sep 9th • 5 mins read

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Virtual, Clinical trials, policy, analytics, telemedicine

The COVID-19 pandemic has significantly impacted clinical research, particularly in oncology, by accelerating the adoption of virtual clinical trials. These trials can address challenges such as high costs and participant burdens associated with traditional trials. Virtual Clinical Trials: Utiliz…

Apr 8th • 4 mins read

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

drug dose, dose, pharmacogenomics, Personalized medicine

Many Americans take medications that are ineffective or cause adverse reactions due to genetic differences in drug metabolism. Pharmacogenomics, the study of how genes affect drug response, can help tailor medications to individual genetic profiles, reducing trial and error in prescriptions. A s…

Sep 27th • 1 min read

Loose Regulatory Standards Portend a New Era of Imprecision Oncology
OVN Avatar Ali Raza Khaki
Loose Regulatory Standards Portend a New Era of Imprecision Oncology

precision oncology, TMB-high, homologous recombination deficiency, Olaparib, pembrolizumab

Precision oncology aims to tailor cancer treatment based on genetic understanding, revolutionizing oncology. The FDA has been approving drugs under precision oncology with broad indications that may not align with studied populations. Examples include the approval of pembrolizumab for a wide ran…

Dec 1st • 4 mins read

A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation
OVN Avatar Jorge J. García, Luis E. Raez, Daniel Rosas
A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation

Biosimilars, interchangeability, extrapolation, immunogenicity

Biologic agents have significantly improved the management of serious health conditions over the last two decades, offering better treatment outcomes and quality of life compared to traditional chemotherapy. The cost of biologic drugs is high, leading to increased healthcare expenses. This mirror…

Aug 3rd • 10 mins read

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
OVN Avatar J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Liquid biopsy, ctDNA, Oncology, Genomic profling, Precision medicine

The proportion of cancer patients with tumors having potentially targetable genomic alterations is increasing. Diagnosing these alterations can lead to tailored treatments and provide additional predictive information on immunotherapy efficacy. In many cases, initial tissue biopsies are ina…

Sep 26th • 17 mins read

Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1
OVN Avatar Daan Geert Knapen, Nathan I. Cherny, Panagiota Zygoura, Nicola Jane Latino, Jean-Yves Douillard, Urania Dafni, Elisabeth G.E. de Vries, Derk Jan de Groot
Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1

ESMO-MCBS, early colon cancer, toxicity, adjuvant chemotherapy, quality of life

Form 1 of the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) is used to grade therapies with curative intent. The study aimed to evaluate the applicability and reasonableness of the ESMO-MCBS scores in early colon cancer. Adjuvant studies were sourced f…

Sep 6th • 17 mins read

Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps
OVN Avatar Carrie Printz
Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps

Precision Medicine, pediatrics, clinical trials

Pediatric precision oncology faces challenges due to the rarity of pediatric cancers, which limits research and funding compared to adult cancers. Dr. Katherine Janeway highlights the need for more validated pre-clinical models and pharmaceutical interest in pediatric cancers. The RACE Act, effe…

Jan 9th • 2 mins read

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

ESMO, MCBS, FDA, ASCO-VF, EMA, QOL

Recent oncology therapies approved by the FDA and EMA often lack evidence of clinically meaningful improvements in quality of life (QOL). Only 40% of FDA-approved and 58% of EMA-approved oncology therapies had published QOL evidence. Clinically meaningful QOL improvements beyond minimal dif…

Feb 11th • 4 mins read

The regulatory landscape of precision oncology laboratory medicine in the United States - Perspective on the past 5 years and considerations for future regulation
OVN Avatar Eric Q. Konnick
The regulatory landscape of precision oncology laboratory medicine in the United States - Perspective on the past 5 years and considerations for future regulation

Oncology, Regulation, Testing, LDTs, FDA, CLIA, CMS

The regulatory landscape for precision oncology in the United States is complex, involving multiple governmental agencies with varying jurisdictions. Since 2014, several regulatory proposals have been introduced following the FDA's draft guidance on laboratory-developed tests. There are ongoing …

May 22nd • 8 mins read

Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015
OVN Avatar Nicole Grossmann, Martin Robausch, Eleen Rothschedl, Claudia Wild, Judit Simon
Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015

Antineoplastic agents, Health-related quality of life, Clinical efficacy, Drug approvals, Patient-relevant outcomes

The study investigates cancer drugs approved by the European Medicines Agency (EMA) that initially lack Health-related Quality of Life (HRQoL) information. Data was collected for cancer indications approved between January 2009 and October 2015, using sources like the EMA website, clinical…

Feb 23rd • 12 mins read

Where Did My Interview Go Wrong?
Partner Avatar Tom Caravela
Where Did My Interview Go Wrong?

interview preparation tips, job interview mistakes, hiring manager feedback, candidate interview performance, professional recruiter advice

During the course of a lengthy and involved interview process, job seekers are often left wondering where they went wrong, or why things didn’t pan out positively in their favor – with a great job offer at the end and an exciting next chapter to look forward to in their professional care…

Apr 24th • 1 min read

Mastering the First Impression
Partner Avatar Tom Caravela
Mastering the First Impression

first impression, job interviews, professional communication, resume tips, LinkedIn profile

Why is a first impression so important? Mainly because it could also be your last, and only, impression on someone. Oftentimes, job seekers can fail at conveying a positive first impression, and they will unfortunately never get another chance to show who they truly are. This is an area that I feel …

Jan 29th • 2 mins read

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion
Partner Avatar Tom Caravela
MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

Medical Science Liaison hiring, diversity and inclusion recruitment, diverse interview panel, employee referral program, diversity sourcing strategies

While the COVID-19 pandemic wreaked havoc on many industries, Medical Science Liaison hiring was steady throughout 2020 and continues to remain strong in 2021. The one change in hiring that has become evident is the increase in recruitment practices that support diversity and inclusion. While we may…

May 19th • 2 mins read

How to Prepare for a Virtual or Video Interview
Partner Avatar Tom Caravela
How to Prepare for a Virtual or Video Interview

virtual interview tips, video interview preparation, mastering virtual communication, professional video interview setup, successful online interview

As we are quickly becoming thrust into the age of “virtual” meetings and video interviews, job seekers and industry professionals need to be completely prepared to master this new paradigm of interpersonal communication. Here are some important tips for acing your next video interview: …

Mar 19th • 1 min read

Resume Writing and Editing Tips for Pharma Professionals
Partner Avatar Tom Caravela
Resume Writing and Editing Tips for Pharma Professionals

Pharmaceutical recruiter, Resume writing tips, Professional CV, LinkedIn profile optimization, Job application keywords

As a Professional Pharmaceutical Recruiter, I read and evaluate resumes (as well as CVs), every day. While I am not a professional resume writer, I have a very strong understanding of what a good resume or CV looks like and what should be included. More importantly, I keep track of what is most effe…

Aug 8th • 1 min read

Presentation Nails and Fails: 7 Tips to Ace Your Next MSL Presentation
Partner Avatar Bridget Rasmusson
Presentation Nails and Fails: 7 Tips to Ace Your Next MSL Presentation

MSL interview tips, scientific presentation skills, hiring managers expectations, medical science liaison communication, virtual interview preparation

The presentation portion of the MSL interview is truly “make or break,” and more often than not, the most highly weighted category of the entire interview process. Countless Hiring Managers have passed on MSL candidates that do not perform well on their scientific presentation – re…

Oct 12th • 1 min read

INTENTION: The Key to Achieving Your Goals
Partner Avatar Tom Caravela
INTENTION: The Key to Achieving Your Goals

digital marketing, search engine optimization, content strategy, keyword research, online visibility

New Years resolutions and goals always seem to follow the same path with the same result. Start…no finish. Beginning…no end. I feel like way too many people make resolutions only to break them a few weeks later. I want to share a strategy that WORKS. Not only will it help you stick to …

Jan 21st • 1 min read

MSL Evolution: New Trends and Titles That May Emerge
Partner Avatar Tom Caravela
MSL Evolution: New Trends and Titles That May Emerge

digital marketing strategies, SEO best practices, content marketing tips, social media optimization, keyword research tools

The COVID-19 pandemic has clearly had a profound impact on Field Medical Affairs. Has the Medical Science Liaison role changed forever? What new titles, trends and opportunities might emerge as a result of the new age for Field Medical and the evolution of the Medical Science Liaison? Is virtual en…

Apr 5th • 1 min read

Promotability: How to Land Your Next Promotion
Partner Avatar Tom Caravela
Promotability: How to Land Your Next Promotion

professional visibility, career advancement, promotion tips, career progression, networking strategies, mentorship benefits, resume upgrades, servant leadership, problem-solving skills, personal branding

“Promotability” may be defined as one’s suitability for being promoted. Is it your goal to obtain a promotion this year? If so, how suitable or promotable are you for that next step? Job-seekers and professionals often ask me what steps are necessary for advancement. I have broken …

May 5th • 10 mins read

Related Topics

Loading...